Variant report
Variant | nsv983762 |
---|---|
Chromosome Location | chr13:88726553-88757094 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-SLITRK5-15 | chr13:88729922-88730495 | NONHSAT034607 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs554989902 | chr13:88726557-88726558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs536899387 | chr13:88726571-88726572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs572791923 | chr13:88726575-88726576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs540268752 | chr13:88726608-88726609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs558642515 | chr13:88726677-88726678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555544363 | chr13:88726715-88726716 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs573470221 | chr13:88726717-88726718 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs188879208 | chr13:88726746-88726747 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544394449 | chr13:88726749-88726750 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs570458764 | chr13:88726750-88726751 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs562691451 | chr13:88726795-88726796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs75298644 | chr13:88726866-88726867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs542086734 | chr13:88726887-88726888 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs565492174 | chr13:88726901-88726902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs557920250 | chr13:88726966-88726967 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs367764067 | chr13:88726986-88726987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs140667984 | chr13:88727013-88727014 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546598884 | chr13:88727026-88727027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs539467176 | chr13:88727028-88727029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs571380023 | chr13:88727045-88727046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs532485780 | chr13:88727079-88727080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs144460776 | chr13:88727080-88727081 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs577788254 | chr13:88727083-88727084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577254237 | chr13:88727106-88727107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs544981452 | chr13:88727142-88727143 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs73578179 | chr13:88727195-88727196 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs192968924 | chr13:88727197-88727198 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs184641610 | chr13:88727211-88727212 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567059038 | chr13:88727271-88727272 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs145434639 | chr13:88727273-88727274 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs558609959 | chr13:88727340-88727341 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs576980719 | chr13:88727410-88727411 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189521890 | chr13:88727459-88727460 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556014852 | chr13:88727460-88727461 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs574573389 | chr13:88727464-88727465 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs116960584 | chr13:88727468-88727469 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs560354929 | chr13:88727475-88727476 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148821977 | chr13:88727507-88727508 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs562328052 | chr13:88727564-88727565 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs564920234 | chr13:88727565-88727566 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7326338 | chr13:88727590-88727591 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs72643089 | chr13:88727592-88727593 | Flanking Active TSS Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs566167130 | chr13:88727593-88727594 | Flanking Active TSS Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs530270012 | chr13:88727607-88727608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34937844 | chr13:88727635-88727636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs6491851 | chr13:88727646-88727647 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs112446072 | chr13:88727669-88727670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs534516085 | chr13:88727686-88727687 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs115213437 | chr13:88727687-88727688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570442550 | chr13:88727707-88727708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
abnormal development | 18461090 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Mental retardation | 17847001 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Non-small cell lung cancer | 16651412 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:88726200-88726600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr13:88726600-88727000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr13:88727000-88727200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr13:88727200-88727600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
5 | chr13:88727200-88727600 | Enhancers | Muscle Satellite Cultured Cells | -- |
6 | chr13:88727200-88727600 | Enhancers | Adipose Nuclei | Adipose |
7 | chr13:88727200-88727600 | Enhancers | Monocytes-CD14+_RO01746 | blood |
8 | chr13:88727400-88727800 | Enhancers | Primary monocytes fromperipheralblood | blood |
9 | chr13:88727600-88728000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr13:88737400-88737600 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr13:88737400-88737800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
12 | chr13:88737800-88738800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
13 | chr13:88737800-88738800 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
14 | chr13:88738200-88739400 | Enhancers | Muscle Satellite Cultured Cells | -- |
15 | chr13:88738800-88739200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
16 | chr13:88738800-88739200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
17 | chr13:88749800-88750400 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
18 | chr13:88755200-88756600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr13:88755800-88756000 | Enhancers | Aorta | Aorta |
20 | chr13:88755800-88756800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
21 | chr13:88756200-88757000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
22 | chr13:88756800-88758600 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
23 | chr13:88757000-88761600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |